Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 1,905 NTRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Natera, Inc. (NTRA) | Grant/Award | 1,905 | n/a |
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| Jun 17, 2025 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 25,000 | $119.8K |
| Jun 28, 2024 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | $88.3K |
| Jun 23, 2023 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Oct 31, 2022 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 32,000 | $263.4K |
| Apr 5, 2019 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 6,296 | n/a |
| Mar 13, 2019 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 5,864 | n/a |